Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (USA) holds 1 active US FDA Type II Drug Master File and 40 inactive, has DMF or CEP filings on record for 25 active ingredients and holds 0 active Type IV (excipient) Drug Master Files. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Bristol-Myers Squibb Company: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/bristol-myers-squibb-company
Overview
Bristol-Myers Squibb Company is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. After acquiring Celgene Corporation in 2019, the company has expanded its portfolio in oncology, hematology, immunology, and cardiovascular disease.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Bristol-Myers Squibb Company holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Bristol-Myers Squibb Company holds 1 active (41 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- MDX-010 (ANTI-CTLA4 HUMAN MONOCLONAL ANTIBODY)Active2005-08-23
- MDX-1100 (ANTI-CXCL 10/ANTI-IP-10 HUMAN MONOCLONAL ANTIBODY)Inactive2005-04-04
- GARENOXACIN MESYLATE (BMS-284756-01) DRUG SUBSTANCEInactive2003-04-22
- HUMAN MONOCLONAL ANTIBODY (MDX-060) TO CD30Inactive2002-04-17
- ARIPIPRAZOLE TABLETSInactive2001-10-05
- AMPHOTERICIN NON PARENTAL GRADEInactive1999-07-08
- IRBESARTANInactive1998-10-08
- CLOXACILLIN SODIUMInactive1998-09-01
- DICLOXACILLIN SODIUMInactive1998-09-01
- NYSTATINInactive1998-09-01
- KANAMYCIN SULFATEInactive1998-09-01
- HETACILLINInactive1998-09-01
- CEPHALEXINInactive1998-09-01
- AMIKACIN SULFATEInactive1998-09-01
- OXACILLIN SODIUMInactive1998-09-01
- PENICILLIN V POTASSIUMInactive1998-09-01
- CEFAZOLIN SODIUMInactive1998-09-01
- AMPICILLIN TRIHYDRATEInactive1998-09-01
- HETACILLIN POTASSIUMInactive1998-09-01
- METHICILLIN SODIUMInactive1998-09-01
- CEFAZOLIN SODIUMInactive1998-09-01
- CEPHRADINEInactive1998-09-01
- CEPHRADINEInactive1998-09-01
- AMIKACIN BASEInactive1998-09-01
- AMPHOTERICIN BInactive1998-09-01
- HETACILLIN POTASSIUMInactive1998-09-01
- DICLOXACILLIN SODIUMInactive1998-09-01
- CEFACLORInactive1998-04-30
- IRBESARTANInactive1998-02-27
- TRIAMCINOLONE DIACETATE, STERILEInactive1995-02-14
- TRIAMCINOLONE HEXACETONIDEInactive1992-08-28
- HETACILLIN POTASSIUMInactive1990-04-05
- 7-AMINO CEPHALOSPORANIC ACID (7-ACA)Inactive1989-06-20
- CRUDE AMPHOTERICIN SLURRYInactive1987-06-26
- PIPERACILLIN MONOHYDRATEInactive1982-02-02
- JM-9 FOR INJECTIONInactive1981-01-29
- WARFARIN SODIUM USPInactive1975-06-10
- 7-ADCAInactive1974-08-27
- HALCINONIDE BULKInactive1973-12-21
- TRIAMCINOLONE AND TRIAMCINOLONE ACETONIDEInactive1970-11-10
- 6-APAInactive1968-06-10
Excipient Drug Master Files
Bristol-Myers Squibb Company holds 0 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- PLASTIBASE 10W (PLASTICIZED HYDROCARBON GEL)Inactive1995-04-20
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Bristol-Myers Squibb Company in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Bristol-Myers Squibb Company?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.